Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shouvik Dass

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Arthritis & Rheumatology (Hoboken, N.J.)|December 7, 2023
Poly-Refractory Rheumatoid Arthritis: An Uncommon Subset of Difficult to Treat Disease With Distinct Inflammatory and Noninflammatory PhenotypesPaula David, Andrea Di Matteo, Or Hen, et al.
Annals of the Rheumatic Diseases|September 26, 2025
Augmentation of immunothrombosis as a key mechanism underlying JAK inhibition associated hypercoagulability in rheumatoid arthritisPaula David, Tom Macleod, Ala Altaie, et al.
The Lancet. Rheumatology|June 14, 2024
The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy managementIan Giles, Iona Thorne, Nanna Surlemont Schmidt, et al.
Rheumatology (Oxford, England)|June 11, 2025
The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitisKathryn Biddle, Judith Jade, Harold Wilson-Morkeh, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Arthritis & Rheumatology (Hoboken, N.J.)|December 7, 2023
Poly-Refractory Rheumatoid Arthritis: An Uncommon Subset of Difficult to Treat Disease With Distinct Inflammatory and Noninflammatory PhenotypesPaula David, Andrea Di Matteo, Or Hen, et al.
Annals of the Rheumatic Diseases|September 26, 2025
Augmentation of immunothrombosis as a key mechanism underlying JAK inhibition associated hypercoagulability in rheumatoid arthritisPaula David, Tom Macleod, Ala Altaie, et al.
The Lancet. Rheumatology|June 14, 2024
The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy managementIan Giles, Iona Thorne, Nanna Surlemont Schmidt, et al.
Rheumatology (Oxford, England)|June 11, 2025
The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitisKathryn Biddle, Judith Jade, Harold Wilson-Morkeh, et al.
Pageof 3